Myriad Genetics
MYGN
#4927
Rank
S$1.93 B
Marketcap
$21.22
Share price
-2.41%
Change (1 day)
-5.28%
Change (1 year)

Myriad Genetics (MYGN) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : S$0.46 Billion

According to Myriad Genetics's latest financial reports the company's total liabilities are S$0.46 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Myriad Genetics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$0.47 B14.38%
2022-12-31S$0.41 B-12.08%
2021-12-31S$0.47 B
2020-06-30S$0.67 B5.74%
2019-06-30S$0.64 B124.8%
2018-06-30S$0.28 B-53.09%
2017-06-30S$0.60 B240.89%
2016-06-30S$0.17 B27.15%
2015-06-30S$0.14 B7.06%
2014-06-30S$0.13 B37.39%
2013-06-30S$95.32 M36.85%
2012-06-30S$69.65 M28.3%
2011-06-30S$54.29 M6.99%
2010-06-30S$50.74 M8.98%
2009-06-30S$46.56 M-53.49%
2008-06-30S$0.10 B85.56%
2007-06-30S$53.95 M27.14%
2006-06-30S$42.44 M8.17%
2005-06-30S$39.23 M51.19%
2004-06-30S$25.95 M-23.56%
2003-06-30S$33.95 M-32.65%
2002-06-30S$50.4 M-15.12%
2001-06-30S$59.38 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$4.19 B 804.12%๐Ÿ‡บ๐Ÿ‡ธ USA
S$4.75 B 926.72%๐Ÿ‡บ๐Ÿ‡ธ USA
S$29.33 M-93.67%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.93 B 317.24%๐Ÿ‡บ๐Ÿ‡ธ USA
S$46.16 B 9,861.69%๐Ÿ‡บ๐Ÿ‡ธ USA